Wealth Enhancement Advisory Services, LLC Abbott Laboratories Put Options Transaction History

Wealth Enhancement Advisory Services, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Oct 23, 2024	BUY	$100.07 - $118.13 $1 Million - $1.18 Million	10,000 Added 833.33%	11,200 $1.28 Million
Q2 2024 Jul 16, 2024	BUY	$100.73 - $112.44 $80,584 - $89,952	800 Added 200.0%	1,200 $124,000
Q1 2024 Apr 15, 2024	SELL	$109.52 - $120.96 $1.18 Million - $1.31 Million	-10,800 Reduced 96.43%	400 $45,000
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $1.07 Million - $1.28 Million	11,200 New	11,200 $1.08 Million

3,161

1.33B

8.63M

7.19M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Wealth Enhancement Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Enhancement Advisory Services, LLC with notifications on news.